argenx SE reported $62.54M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
AstraZeneca USD 1.55B 28K Sep/2026
Genmab DKK 61.44M 181K Jun/2026
GlaxoSmithKline GBP 2.02B 2.05B Sep/2026
GRIFOLS EUR 680.58M 0 Sep/2026
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Lakefront Biotherapeutics EUR 65.66M 0 Sep/2026
Qiagen NV USD 206.5M 245K Jun/2026
UCB EUR 190.36M 365.15K Dec/2025